IRTC

BTIG analyst Marie Thibault reiterated a Buy rating on Irhythm Technologies (IRTC – Research Report) today and set a price target of $155.00. The company's shares closed last Monday at $142.31. According to TipRanks.com, Thibault is a 4-star analyst with an average return of 6.5% and a 31.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Boston Scientific. Irhythm Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $155.14, representing a 6.8% upside. In a report issued on July 8, Truist Financial also maintained a Buy rating on the stock with a $165.00 price target.
https://www.tipranks.com/news/blurbs/btig-reiterates-a-buy-rating-on-irhythm-technologies-irtc?utm_source=advfn.com&utm_medium=referral